GFPC
IDXX icon

Global Financial Private Client’s Idexx Laboratories IDXX Stock Holding History

Global Financial Private Client’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7
Closed -$2.94K – 856
2025
Q1 		$2.94K Buy
7
+5
+250% +$2.17K ﹤0.01% 776
2024
Q4 		$827 Buy
+2
New +$877 ﹤0.01% 818

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Global Financial Private Client's IDXX Position: Q2 2025 in Review

Global Financial Private Client sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 7 shares — an estimated $2.94K sold.

Global Financial Private Client first reported a position in IDXX in Q4 2024 and held it in 2 quarters. The position peaked at $2.94K in Q1 2025. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Global Financial Private Client reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Global Financial Private Client sold 7 Idexx Laboratories shares in Q2 2025, an estimated $2.94K.
  • Global Financial Private Client first reported a position in Idexx Laboratories in Q4 2024 and held it in 2 quarters.
  • Global Financial Private Client's Idexx Laboratories position peaked at $2.94K in Q1 2025.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.